Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPREDNISOLONE HEMISUCCINATE: 153 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
153
Total FAERS Reports
24 (15.7%)
Deaths Reported
76
Hospitalizations
153
As Primary/Secondary Suspect
18
Life-Threatening
4
Disabilities

First Report: 200402 · Latest Report: 20250514

What Are the Most Common METHYLPREDNISOLONE HEMISUCCINATE Side Effects?

#1 Most Reported
Hypotension
12 reports (7.8%)
#2 Most Reported
Pyrexia
10 reports (6.5%)
#3 Most Reported
Off label use
10 reports (6.5%)

All METHYLPREDNISOLONE HEMISUCCINATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Hypotension 12 7.8% 4 8
Off label use 10 6.5% 1 3
Pyrexia 10 6.5% 4 9
Hepatocellular injury 9 5.9% 0 6
Sepsis 9 5.9% 6 6
Septic shock 9 5.9% 7 7
Hypersensitivity 8 5.2% 0 6
Dyspnoea 7 4.6% 2 4
Abdominal pain 6 3.9% 2 2
Erythema 6 3.9% 0 2
Febrile bone marrow aplasia 6 3.9% 1 5
Hyperthermia 6 3.9% 3 3
Multiple organ dysfunction syndrome 6 3.9% 6 5
Oxygen saturation decreased 6 3.9% 1 4
Pneumonia 6 3.9% 1 5
Pruritus 6 3.9% 0 1
Tachycardia 6 3.9% 0 3
Aplasia 5 3.3% 2 4
Cough 5 3.3% 2 2
Epilepsy 5 3.3% 0 3

Who Reports METHYLPREDNISOLONE HEMISUCCINATE Side Effects? Age & Gender Data

Gender: 53.2% female, 46.8% male. Average age: 49.6 years. Most reports from: FR. View detailed demographics →

Is METHYLPREDNISOLONE HEMISUCCINATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2004 2 2 2
2009 1 0 0
2010 2 0 0
2011 1 0 1
2012 1 0 0
2014 2 0 2
2015 4 3 4
2016 1 0 1
2017 4 0 4
2018 30 6 19
2019 22 1 10
2020 11 1 5
2021 11 4 5
2022 11 0 3
2023 13 4 8
2024 10 0 4
2025 6 0 0

View full timeline →

What Is METHYLPREDNISOLONE HEMISUCCINATE Used For?

IndicationReports
Premedication 20
Chemotherapy side effect prophylaxis 14
Prophylaxis of nausea and vomiting 9
Chemotherapy 6
Multiple sclerosis 6
Product used for unknown indication 5
Prophylaxis against transplant rejection 5
Systemic lupus erythematosus 5

METHYLPREDNISOLONE HEMISUCCINATE vs Alternatives: Which Is Safer?

METHYLPREDNISOLONE HEMISUCCINATE vs METILDIGOXIN METHYLPREDNISOLONE HEMISUCCINATE vs METOCLOPRAMIDE METHYLPREDNISOLONE HEMISUCCINATE vs METOLAZONE METHYLPREDNISOLONE HEMISUCCINATE vs METOPIMAZINE METHYLPREDNISOLONE HEMISUCCINATE vs METOPROLOL METHYLPREDNISOLONE HEMISUCCINATE vs METRELEPTIN METHYLPREDNISOLONE HEMISUCCINATE vs METRONIDAZOLE METHYLPREDNISOLONE HEMISUCCINATE vs METRONIDAZOLE\METRONIDAZOLE METHYLPREDNISOLONE HEMISUCCINATE vs METYRAPONE METHYLPREDNISOLONE HEMISUCCINATE vs MEXILETINE

Official FDA Label for METHYLPREDNISOLONE HEMISUCCINATE

Official prescribing information from the FDA-approved drug label.